La malatie di Alzheimer e à, in gjenerâl, une prognosi negative, parcè che e je une cundizion progressive e degenerative cence cure cognossude. ❚
La velocitât de progression e varie di persone a persone, ma la malatie e va in piês cul timp, puartant a un declin des abilitâts cognitivis e fisichis.
Man man che la malatie e progredis, i individuis a puedin vê pierdite di memorie, dificoltât cul lengaç e la comunicazion, disorientament e cambiaments dal umôr e dal compuartament.
A la fin, a puedin no jessi plui in grât di curâsi e a àn bisugne di un jutori a timp plen. ❚
La medie de sperance di vite dopo la diagnosi e je di 8-10 agns, ma chest al pues variâ une vore a seconde de etât dal individui, de salût gjenerâl e di altris fatôrs.
Ancje se no je une cure, lis curis a puedin judâ a gjestî i sintoms e a miorâ la cualitât de vite pes personis cul morbil di Alzheimer.
Kaldjian LC: Survival versus prognosis in Alzheimer disease. Ann Intern Med. 2004, 141 (7): 575; author reply 575.
Mayeux R, Stern Y, Sano M: Heterogeneity and prognosis in dementia of the Alzheimer type. Bull Clin Neurosci. 1985, 50 (): 7-10.
DeKosky ST, Golde T: Cerebrospinal Biomarkers in Alzheimer Disease-Potential Roles as Markers of Prognosis and Neuroplasticity. JAMA Neurol. 2016, 73 (5): 508-10.
Yaffe K: Treatment of Alzheimer disease and prognosis of dementia: time to translate research to results. JAMA. 2010, 304 (17): 1952-3.
Zhu B, Chen X, Li W, Zhou D: Effect of Alzheimer Disease on Prognosis of Intensive Care Unit (ICU) Patients: A Propensity Score Matching Analysis. Med Sci Monit. 2022, 28 (): e935397.
Malpetti M, Joie R, Rabinovici GD: Tau Beats Amyloid in Predicting Brain Atrophy in Alzheimer Disease: Implications for Prognosis and Clinical Trials. J Nucl Med. 2022, 63 (6): 830-832.
Schaeffer EL, Figueiro M, Gattaz WF: Insights into Alzheimer disease pathogenesis from studies in transgenic animal models. Clinics (Sao Paulo). 2011, 66 Suppl 1 (): 45-54.
Bhagwat N, Pipitone J, Voineskos AN, Chakravarty MM: An artificial neural network model for clinical score prediction in Alzheimer disease using structural neuroimaging measures J Psychiatry Neurosci. 2019, 44 (4): 246-260.
Vermunt L, van Paasen AJL, Teunissen CE, Scheltens P, Visser PJ, Tijms BM: Alzheimer disease biomarkers may aid in the prognosis of MCI cases initially reverted to normal. Neurology. 2019, 92 (23): e2699-e2705.
Raji MA, Brady SR: Mirtazapine for treatment of depression and comorbidities in Alzheimer disease. Ann Pharmacother. 2001, 35 (9): 1024-7.
['Disclaimer: medicâl']
['Chest sît web al è furnît dome par fins educatîfs e informatîfs e nol è une consulence o un servizi professionâl.']
['Lis informazions furnidis no àn di jessi dopradis par diagnosticâ o curâ un probleme di salût o une malatie, e chei che a vuelin une consulence mediche personâl a àn di consultâ un miedi autorizât.']
['Par plasê note che la rêt neuronâl che a gjenere lis rispuestis aes domandis, e je imprecise soredut cuant a si trate di contignûts numerics.']
['Cîr simpri la consulence dal to miedi o di un altri professionist in materie di salût a rivuart di une malatie. No sta mai dismenteâ la consulence di un miedi professionist o intardâti a cirîle par vie di alc che tu âs let su chest sît. Se tu pensis di vê une emergjence mediche, clame il 911 o va tal pronto socorso plui dongje.']
['Disclaimer: copyright']
['Il Digital Millennium Copyright Act dal 1998, 17 U.S.C. § 512 (il DMCA) al proviôt un ricors pai proprietaris di copyright che a crodin che il materiâl che al comparìs su Internet al violi i lôr dirits sot la leç sul copyright dai Stâts Unîts. ']
['Se tu crodis in buine fede che cualsisei contignût o materiâl disponibil in conession cul nestri sît o i nestris servizis al violi il tô copyright, tu (o il to agjent) tu puedis mandânus une notifiche domandant la rimozion dal contignût o dal materiâl, o il bloc dal acès. ']
['I avîs a àn di jessi mandâts par scrit vie e-mail (cjale la sezion "Contat" par vê l\'indiriç e-mail). ']
['La DMCA e domande che la tô notifiche di violazion dal copyright e vedi dentri chestis informazions: (1) descrizion dal lavôr protet dal copyright che al è ogjet de violazion rivendicade; (2) descrizion dal presunt contignût che al è une violazion e informazions suficientis par permeti di cjatâ il contignût; (3) informazions di contat, includût la tô direzion, numar di telefon e pueste eletroniche; (4) une declarazion di buine fede che il contignût al no è autorizât dal proprietari dal copyright, o dal so agjent, o par vie di une leç; ']
['5) une declarazion di bande tô, firmade sot pena di falsetât, che lis informazions inte notifiche a son veris e che tu âs la autoritât par fâ valê i dirits di autôr che a son stâts violats;']
['e (6) une firme fisiche o eletroniche dal titulâr dal copyright o di une persone autorizade a agjî par cont dal titulâr. ']
['Se no tu âs dutis lis informazions parsore, al podarès intardâ il tratament dal to reclam.']
['Contatât']
['Par plasê mandinus une e-mail cun ogni domande / sugjeriment.']
What is prognosis of alzheimer?
The prognosis of Alzheimer's disease is generally poor, as it is a progressive and degenerative condition with no known cure.
The rate of progression varies from person to person, but the disease typically worsens over time, leading to a decline in cognitive and physical abilities.
As the disease progresses, individuals may experience memory loss, difficulty with language and communication, disorientation, and changes in mood and behavior.
Eventually, they may become unable to care for themselves and require full-time assistance.
The average life expectancy after diagnosis is around 8-10 years, but this can vary widely depending on the individual's age, overall health, and other factors.
While there is no cure, treatments and therapies can help manage symptoms and improve quality of life for those with Alzheimer's disease.
Disclaimer: medical
This web site is provided for educational and informational purposes only and does not constitute providing medical advice or professional services.
The information provided should not be used for diagnosing or treating a health problem or disease, and those seeking personal medical advice should consult with a licensed physician.
Please note the neural net that generates answers to the questions, is specially inaccurate when it comes to numeric content. For example, the number of people diagnosed with a specific disease.
Always seek the advice of your doctor or other qualified health provider regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website. If you think you may have a medical emergency, call 911 or go to the nearest emergency room immediately. No physician-patient relationship is created by this web site or its use. Neither BioMedLib nor its employees, nor any contributor to this web site, makes any representations, express or implied, with respect to the information provided herein or to its use.
Disclaimer: copyright
The Digital Millennium Copyright Act of 1998, 17 U.S.C. § 512 (the “DMCA”) provides recourse for copyright owners who believe that material appearing on the Internet infringes their rights under U.S. copyright law. If you believe in good faith that any content or material made available in connection with our website or services infringes your copyright, you (or your agent) may send us a notice requesting that the content or material be removed, or access to it blocked. Notices must be sent in writing by email (see 'Contact' section for email address) . The DMCA requires that your notice of alleged copyright infringement include the following information: (1) description of the copyrighted work that is the subject of claimed infringement; (2) description of the alleged infringing content and information sufficient to permit us to locate the content; (3) contact information for you, including your address, telephone number and email address; (4) a statement by you that you have a good faith belief that the content in the manner complained of is not authorized by the copyright owner, or its agent, or by the operation of any law; (5) a statement by you, signed under penalty of perjury, that the information in the notification is accurate and that you have the authority to enforce the copyrights that are claimed to be infringed; and (6) a physical or electronic signature of the copyright owner or a person authorized to act on the copyright owner’s behalf. Failure to include all of the above information may result in the delay of the processing of your complaint.
['A rivuart']
['BioMedLib al dopre ordenadôrs automatics (algoritmi di aprendiment de machine) par gjenerâ cubiis di domandis e rispuestis.']
['Si scomence cun 35 milions di publicazions biomedichis di PubMed/Medline. e ancje lis pagjinis web di RefinedWeb.']
